QQ客服 官方微博 反馈留言

	A monoclonal antibody targeting ErbB2 domain III inhibits ErbB2 signaling and suppresses the growth of ErbB2-overexpressing breast tumors.
	Y Meng; L Zheng; Y Yang; H Wang; J Dong; C Wang; Y Zhang; X Yu; L Wang; T Xia
刊名	Oncogenesis
	2016
卷号	Vol.5页码:e211
ISSN号	2157-9024
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1863781
专题	南开大学
作者单位	School of Medicine, Nankai University, Tianjin, People's Republic of China2International Joint Cancer Institute, the Second Military Medical University, Shanghai, People's Republic of China3Department of Vascular Surgery, Changhai Hospital, Second Military Medical University, Shanghai, People's Republic of China4State Key Laboratory of Antibody Medicine and Targeted Therapy, Shanghai, People's Republic of China
推荐引用方式 GB/T 7714	Y Meng,L Zheng,Y Yang,et al. A monoclonal antibody targeting ErbB2 domain III inhibits ErbB2 signaling and suppresses the growth of ErbB2-overexpressing breast tumors.[J]. Oncogenesis,2016,Vol.5:e211.
APA	Y Meng.,L Zheng.,Y Yang.,H Wang.,J Dong.,...&B Li.(2016).A monoclonal antibody targeting ErbB2 domain III inhibits ErbB2 signaling and suppresses the growth of ErbB2-overexpressing breast tumors..Oncogenesis,Vol.5,e211.
MLA	Y Meng,et al."A monoclonal antibody targeting ErbB2 domain III inhibits ErbB2 signaling and suppresses the growth of ErbB2-overexpressing breast tumors.".Oncogenesis Vol.5(2016):e211.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。